0001140361-17-011623.txt : 20170310
0001140361-17-011623.hdr.sgml : 20170310
20170310161851
ACCESSION NUMBER: 0001140361-17-011623
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170308
FILED AS OF DATE: 20170310
DATE AS OF CHANGE: 20170310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hauer Jerome M
CENTRAL INDEX KEY: 0001294935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 17682389
MAIL ADDRESS:
STREET 1: 4435 EASTGATE MALL
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc1.xml
FORM 4
X0306
4
2017-03-08
0
0001367644
Emergent BioSolutions Inc.
EBS
0001294935
Hauer Jerome M
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2016-08-01
4
J
0
453
0
A
17404
D
Common Stock
2016-08-01
4
J
0
604
0
A
18008
D
Common Stock
2016-08-01
4
J
0
577
0
A
18585
D
Common Stock
2017-03-08
4
S
0
2576
31.2727
D
16009
D
Employee Stock Option (Right to buy)
25.47
2016-08-01
4
J
0
905
0
A
2022-01-21
Common Stock
10305
10305
D
In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as
a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in January 2018.
In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as
a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017 and May 2018.
In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as
a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.25 to $31.32, inclusive.
Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant.
The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
/s/ Eric Burt, Attorney-in-fact
2017-03-10